Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 841 results for "Novartis Company"

Judge says Novartis can launch biosimilar of Amgen's Neupogen

Novartis ($NVS) CEO Joe Jimenez was a bit dismissive about the immediate impact of biosimilars when his company became the first to get one approved in the U.S. But Amgen ($AMGN) didn't see the biosimilar of its blockbuster Neupogen in quite the ... FiercePharma, 1 week ago

44 images for Novartis Company

West Australian, 6 days ago
NPR, 3 weeks ago
Jutia Group, 4 days ago
Business Insider, 3 weeks ago
Yahoo! Green, 3 weeks ago
Citybizlist, 6 days ago
Irish Times, 3 weeks ago
Reuters, 3 weeks ago, 3 weeks ago
Oregon Public Broadcasting, 3 weeks ago

The top 15 pharma companies by 2014 revenue

The names at the very top of our yearly list of biggest pharma companies are no surprise. Johnson & Johnson ( $JNJ ), Novartis ( $NVS ), Roche ( $RHHBY ) and Pfizer ( $PFE ) have headed up the rankings for a couple of years now, albeit in varying ...
 FiercePharma1 week ago Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025  Global Information Inc4 days ago A BAD YEAR FOR TOP MNCs  PharmaBiz4 days ago

GSK share price: Group expects to wrap up Novartis deal next week

GlaxoSmithKline Plc (LON:GSK), the UK's largest drugmaker, yesterday announced that the company expects to conclude its multibillion dollar deal with Novartis next week. According to the FTSE 100 drugmaker, the wrapping up of the three-part asset ...
 Invezz1 week ago GSK share price flat as Novartis deal passes hurdle Down Under  Invezz1 week ago GSK share price: Company presses ahead with £4bn capital return  Invezz1 week ago GSK completes transaction with Novartis  Business Standard3 weeks ago
Money Today

GSK and Novartis complete deals to reshape both drugmakers

GSK is forming a consumer health joint venture with Novartis, while at the same time buying the Swiss company's vaccines business. LONDON: GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that ...
 Economic Times3 weeks ago GSK set to complete $20 bn Novartis asset swap next week  Money Today1 month ago 'I watch the consumer more than the competition'  Money Today1 month ago

Novartis drops after reporting loss in Q3

The company reported a loss of Rs 1.18 crore for quarter ended December 2014 against a profit of Rs 15.2 crore in the quarter ended December 2013 SI Reporter | Mumbai February 5, 2015 Last Updated at 11:32 IST
 Business Standard1 month ago Novartis Q3 net loss at Rs 1.18 crore  Business Standard1 month ago
Business Standard

Life and lung issue in Cipla-Novartis battle

e with respiratory ailments have a big personal stake in the legal wrangle between drug companies Cipla and Novartis over Onbrez, the drug used to treat the condition. According to the World Health Organisation, India has an estimated 10.2 million persons ...
 Business Standard2 months ago High Court notice to Novartis on Cipla appeal  Down to Earth2 months ago HC notice to Novartis on Cipla plea  Deccan Herald2 months ago Delhi High Court bars Cipla from selling copy of Novartis respiratory drug  Business Standard2 months ago
Money Control

GSK Pharma to move cancer drug portfolio to Novartis arm

"Pursuant to the global deal, the company will have its distribution rights terminated for the oncology portfolio in return for accessing the distribution rights of the acquired vaccines portfolio," GlaxoSmithKline Pharmaceuticals Ltd said in a filing to the ...
 Money Control1 month ago

Novartis profits jump 12 per cent on new drug sales

During 2014, the Basel-based company said its net profit rose to $12.7 billion, while sales rose one per cent year-on-year to $57.9 billion. The results were largely in line with expectations, with analysts polled by the AWP financial news agency anticipating ...
 Economic Times2 months ago

Novartis takes RTI route, blocks local firm's bid to copy anti-diabetes drug

Swiss pharmaceutical giant Novartis has restrained a local pharma company from making anti-diabetes drug by approaching a court because the MNC had patented the drug and is enjoying monopoly over its production and sale.
 Times of India2 months ago

Novartis India slips as board approves transfer of OTC business

Novartis India fell 1.4% to Rs 663 at 11:36 IST on BSE after the company's board of directors approved the transfer of its OTC division to GlaxoSmithKline Consumer as part of its global portfolio transformation. Meanwhile, the BSE Sensex was down 56.40 ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Novartis Company
Get updated on latest news & your favorite topics right in your inbox!
More     Less